| 3207 |
2226: Binding PPAR isoforms |
2224: Dysregulation of transcriptional expression within PPAR signaling network |
May 8, 2024 |
May 8, 2024 |
None
|
| 3208 |
2226: Binding PPAR isoforms |
179: Decrease, Fatty acid β-oxidation |
May 8, 2024 |
May 8, 2024 |
None
|
| 3220 |
2226: Binding PPAR isoforms |
2227: Disrupted PPAR isoform nuclear signaling |
May 14, 2024 |
May 23, 2024 |
1 AOP
|
| 3399 |
2279: Structural changes in lamin A/C |
2066: Altered Signaling |
Nov 20, 2024 |
Nov 20, 2024 |
1 AOP
|
| 1968 |
1671: Substance - LS interaction |
1672: Inhibition of LS function. |
Jul 3, 2019 |
Jul 3, 2019 |
None
|
| 1702 |
1495: Interaction with the lung cell membrane |
1496: Increased proinflammatory mediators |
Jan 5, 2018 |
Feb 20, 2025 |
3 AOPs
|
| 2662 |
1495: Interaction with the lung cell membrane |
1115: Increase, ROS |
May 25, 2022 |
May 25, 2022 |
1 AOP
|
| 2663 |
1495: Interaction with the lung cell membrane |
1669: Increased, DNA damage and mutation |
May 25, 2022 |
May 25, 2022 |
1 AOP
|
| 2958 |
1495: Interaction with the lung cell membrane |
1438: Increased transcription of genes encoding acute phase proteins |
Jul 4, 2023 |
Jan 20, 2025 |
1 AOP
|
| 2959 |
1495: Interaction with the lung cell membrane |
1439: Systemic acute phase response |
Jul 4, 2023 |
Jan 20, 2025 |
1 AOP
|
| 2960 |
1495: Interaction with the lung cell membrane |
1443: Atherosclerosis |
Jul 4, 2023 |
Feb 19, 2025 |
1 AOP
|
| 3303 |
2243: Succinate Accumulation |
1619: Increase, DNMT inhibition |
Jul 18, 2024 |
Jul 18, 2024 |
1 AOP
|
| 3304 |
2243: Succinate Accumulation |
798: Inhibition, Prolyl hydroxylases |
Jul 18, 2024 |
Jul 18, 2024 |
1 AOP
|
| 2866 |
2118: SDH, inhibited |
2120: Superoxide generation, increased |
Apr 3, 2023 |
May 4, 2023 |
1 AOP
|
| 3233 |
2118: SDH, inhibited |
1446: Decrease, Coupling of OXPHOS |
May 28, 2024 |
May 28, 2024 |
1 AOP
|
| 3302 |
2118: SDH, inhibited |
2243: Succinate Accumulation |
Jul 18, 2024 |
Jul 18, 2024 |
2 AOPs
|
| 3554 |
2118: SDH, inhibited |
177: Increase, Mitochondrial dysfunction |
Aug 1, 2025 |
Aug 1, 2025 |
1 AOP
|
| 3273 |
2120: Superoxide generation, increased |
1392: Increase, Oxidative Stress |
Jul 4, 2024 |
Jul 4, 2024 |
1 AOP
|
| 1817 |
1565: Suppressed AP-1 |
1567: Suppressed DC activation |
Dec 25, 2018 |
Dec 25, 2018 |
None
|
| 1819 |
1567: Suppressed DC activation |
1568: Impaired antigen presentation |
Dec 25, 2018 |
Dec 25, 2018 |
None
|
| 1826 |
1573: Suppressed MyD88 |
986: Impairment of TDAR |
Jan 6, 2019 |
Jan 6, 2019 |
None
|
| 1870 |
1573: Suppressed MyD88 |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Mar 12, 2019 |
Mar 12, 2019 |
None
|
| 1818 |
1566: Suppressed NF-kB |
1567: Suppressed DC activation |
Dec 25, 2018 |
Dec 25, 2018 |
None
|
| 2001 |
1702: Suppression of T cell activation |
202: Inhibition, Nuclear factor kappa B (NF-kB) |
Nov 17, 2019 |
Nov 17, 2019 |
None
|
| 2004 |
1702: Suppression of T cell activation |
986: Impairment of TDAR |
Nov 17, 2019 |
Mar 2, 2023 |
None
|